Micellar delivery of bicalutamide and embelin for treating prostate cancer

Pharmaceutical Research

Volumn 26, Issue 9, 2009, Pages 2081-2092

  Danquah, Michael ^a   Li, Feng ^a   Duke III, Charles B ^a   Miller, Duane D ^a   Mahato, Ram I ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Androgen; Bicalutamide; Embelin; Micelles; Prostate cancer

Indexed keywords

ANDROGEN; BICALUTAMIDE; CASPASE 3; CASPASE 8; CASPASE 9; EMBELIN; MACROGOL; POLYLACTIC ACID; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER MODEL; CELL STRAIN LNCAP; CELL VIABILITY; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG STRUCTURE; ENCAPSULATION; ENZYME ACTIVATION; EVALUATION; EXPERIMENTAL NEOPLASM; HUMAN; HUMAN CELL; IC 50; MALE; MICELLE; MOUSE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; NUDE MOUSE; PARTICLE SIZE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SOLUBILIZATION; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR REGRESSION; TUMOR XENOGRAFT;

ANILIDES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BASE SEQUENCE; BENZOQUINONES; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; MALE; MICE; MICE, NUDE; MICELLES; NITRILES; PROSTATIC NEOPLASMS; TOSYL COMPOUNDS; TRANSPLANTATION, HETEROLOGOUS;

EID: 68149132860     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9903-5     Document Type: Article

References (44)

1. A Jemal R Siegel E Ward Y Hao J Xu T Murray 2008 Cancer statistics, 2008 CA 58 71 96
2. C Huggins CV Hodges 1941 Studies on prostatic cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate Cancer Res 1 293 297
3. GR Cunha AA Donjacour PS Cooke S Mee RM Bigsby SJ Higgind 1987 The endocrinology and developmental biology of the prostate Endocr Rev 8 338 362 doi:10.1210/edrv-8-3-338
4. JT Isaacs 1994 Role of androgens in prostate cancer Vitam Horm 49 433 502 doi:10.1016/S0083-6729(08)61152-8
5. JT Arnold JT Isaacs 2002 Mechanisms involved in the progression of androgen-independent prostate cnacers: it is not only the cancer cell's fault Endocr Relat Cancer 9 61 73 doi:10.1677/erc.0.0090061 (Pubitemid 34298364)
6. M Miquel A Soler A Vaque I Ojanguren J Costa R Planas 2007 Suspected cross-hepatotoxicity of flutamide and cyproterone acetate Liver Int 27 1144 1147 doi:10.1111/j.1478-3231.2007.01549.x (Pubitemid 47399450)
7. HJ de Voogt PH Smith M Pavone-Macaluso M de Pauw S Suciu 1986 Cardiovascular side effects of diethylstilbestrol, cyproterone acetate, medroxyprogesterone acetate and estramustine phosphate used for the treatment of advanced prostatic cancer: results from European Organization for Research on Treatment of Cancer trials 30761 and 30762 J Urol 135 303 307
8. G Blackledge 1993 Casodex-mechanism of action and opportunity for usage Cancer 72 3830 3833
9. QL Deveraux JC Reed 1999 IAP family proteins-suppressors of apoptosis Genes Dev 13 239 252 doi:10.1101/gad.13.3.239
10. GM Kasof BC Gomes 2001 Livin, a novel inhibitor of apoptosis protein family member J Biol Chem 276 3238 3246 doi:10.1074/jbc.M003670200
11. GS Salvesen CS Duckett 2002 IAP proteins: blocking the road to death's door Nat Rev Mol Cell Biol 3 401 410 doi:10.1038/nrm830 (Pubitemid 34685698)
12. R Takahashi Q Deveraux I Tamm K Welsh N Assa-Munt GS Salvesen 1998 A single BIR domain of XIAP sufficient for inhibiting caspases J Biol Chem 273 7787 7790 doi:10.1074/jbc.273.14.7787 (Pubitemid 28168819)
13. SW Fesik 2000 Insights into programmed cell death through structural biology Cell 103 273 282 doi:10.1016/S0092-8674(00)00119-7
14. SJ Riedl M Renatus R Schwarzenbacher Q Zhou C Sun SW Fesik 2001 Structural basis for the inhibition of caspase-3 by XIAP Cell 104 791 800 doi:10.1016/S0092-8674(01)00274-4
15. J Chai E Shiozaki SM Srinivasula Q Wu P Datta ES Alnemri 2001 Structural basis of caspase-7 inhibition by XIAP Cell 104 769 780 doi:10.1016/S0092- 8674(01)00272-0
16. KR McEleny RW Watson RN Coffey AJ O'Neill JM Fitzpatrick 2002 Inhibitors of apoptosis proteins in prostate cancer cell lines Prostate 51 133 140 doi:10.1002/pros.10061 (Pubitemid 34492620)
17. M Krajewska S Krajewski S Banares X Huang B Turner L Bubendorf 2003 Elevated expression of inhibitor of apoptosis proteins in prostate cancer Clin Cancer Res 9 4914 4925
18. Z Nikolovska-Coleska L Xu Z Hu Y Tomita P Li PP Roller 2004 Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database J Med Chem 47 2430 2440 doi:10.1021/jm030420+ (Pubitemid 38580082)
19. M Chitra E Sukumar V Suja CS Devi 1994 Antitumor, anti-inflammatory and analgesic property of embelin, a plant product Chemotherapy 40 109
20. EK Githui DW Makawiti JO Midiwo 1991 Changes in the concentrations of testosterone, luteinising hormone and progesterone associated with administration of embelin Contraception 44 311 317 doi:10.1016/0010-7824(91) 90020-G
21. KS Ahn G Sethi BB Aggarwal 2007 Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-kappaB (NF-kappaB) signaling pathway leading to suppression of NF-kappaB-regulated antiapoptotic and metastatic gene products Mol Pharmacol 71 209 219 doi:10.1124/mol.106.028787 (Pubitemid 46020991)
22. A Lavasanifar J Samuel GS Kwon 2002 Poly(ethylene oxide)-block-poly(l- amino acid) micelles for drug delivery Adv Drug Deliv Rev 54 169 190 doi:10.1016/S0169-409X(02)00015-7 (Pubitemid 34230440)
23. Y Yamamoto Y Nagasaki Y Kato Y Sugiyama K Kataoka 2001 Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge J Control Release 77 27 38 doi:10.1016/S0168-3659(01)00451-5 (Pubitemid 33022613)
24. H Maeda J Wu T Sawa Y Matsumura K Hori 2000 Tumor vasculature permeability and the EPR effect in macromolecular therapeutics: a review J Control Release 65 271 284 doi:10.1016/S0168-3659(99)00248-5 (Pubitemid 30122932)
25. H Maeda T Sawa T Konno 2001 Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS J Control Release 74 47 61 doi:10.1016/S0168-3659(01)00309-1 (Pubitemid 32727608)
26. A Mukherjee L Kirkovsky XT Yao RC Yates DD Miller JT Dalton 1996 Enantioselective binding of Casodex to the androgen receptor Xenobiotica 26 117 122
27. GG Steel MJ Peckham 1979 Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity Int J Radiat Oncol Biol Phys 5 85 91
28. KP Ananthapadmanabhan ED Goddard NJ Turro PL Kuos 1985 Fluorescence Probes for Critical Micelle Concentration Langmuir 1 352 355 doi:10.1021/la00063a015
29. JS Ham 1953 A New Electronic State in Benzene J Chem Phys 21 756 758 doi:10.1063/1.1699014
30. M Wilihelm CL Zhao Y Wang R Xu MA Winnik 1991 Poly(styrene-ethylene oxide) block copolymer micelle formation in water: A fluorescence probe study Macromolecules 24 1033 1040 doi:10.1021/ma00005a010
31. E Blanco EA Bey Y Dong BD Weinberg DM Sutton DA Boothman 2007 b-Lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells J Control Release 122 365 374 doi:10.1016/j.jconrel.2007.04.014 (Pubitemid 47404665)
32. ME Grossmann H Huang DJ Tindall 2001 Androgen receptor signaling in androgen-refractory prostate cancer J Natl Cancer Inst 93 1687 1697 doi:10.1093/jnci/93.22.1687
33. JA Kish R Bukkapatnam F Palazzo 2001 The treatment challenge of hormone-refractory prostate cancer Cancer Control 8 487 495
34. JJ Knox MJ Moore 2001 Treatment of hormone refractory prostate cancer Semin Urol Oncol 19 202 211
35. H Rubben A Bex T Otto 2001 Systemic treatment of hormone refractory prostate cancer World J Urol 19 99 110 doi:10.1007/s003450000186
36. JA Emamaullee AM Shapiro 2006 Interventional strategies to prevent beta-cell apoptosis in islet transplantation Diabetes 55 1907 1914 doi:10.2337/db05-1254 (Pubitemid 44509961)
37. EC Lee P Zhan R Schallhom K Packman M Tenniswood 2003 Antiandrogen-induced cell death in LNCaP human prostate cancer cells Cell Death Differ 10 761 771 doi:10.1038/sj.cdd.4401228 (Pubitemid 36850237)
38. X Liao S Tang JB Thrasher TL Griebling B Li 2005 Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer Mol Cancer Ther 4 505 515 doi:10.1158/1535-7163.MCT-04-0313 (Pubitemid 40601831)
39. T Yoshida H Kinoshita T Segawa E Nakamura T Inoue Y Shimizu 2005 Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient Cancer Res 65 9611 9616 doi:10.1158/0008-5472.CAN-05-0817 (Pubitemid 41541433)
40. M Fakler S Loder M Vogler K Schneider I Jeremias KM Debatin 2009 Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance Blood 113 8 1710 1722
41. M Akutsu Y Kano S Tsunoda K Suzuki Y Yazawa Y Miura 1995 Schedule-dependent interaction between paclitaxel and doxorubicin in human cancer cell lines in vitro Eur J Cancer 31A 2341 2346 doi:10.1016/0959-8049(95) 00448-3 (Pubitemid 26050581)
42. X Yang B Zhu T Dong P Pan X Shuai Y Inoue 2008 Interactions between an anticancer drug and polymeric micelles based on biodegradable polyesters Macromol Biosci 8 1116 1125 doi:10.1002/mabi.200800085
43. FM Sirotnak Y She F Lee J Chen HI Scher 2002 Studies with CWR22 xenografts in nude mice suggest that ZD1839 may have a role in the treatment of both androgen-dependent and androgen-independent human prostate cancer Clin Cancer Res 8 3870 3876
44. RA Burich WS Holland RL Vinall C Tepper RW White PC Mack 2008 Genistein combined polysaccharide enhances activity of docetaxel, bicalutamide and Src kinase inhibition in androgen-dependent and independent prostate cancer cell lines BJU Int 102 1458 1466